Remedium Lifecare, which is mainly engaged in the pharmaceutical sector, has informed exchanges that its board of directors will meet soon to consider the acquisition of a manufacturing facility near Hyderabad. According to an exchange filing, the facility produces intermediates for the pharmaceutical industry.
The company also said that the trading window will be closed from today and shall remain closed until 48 hours after the declaration of the outcome of the meeting.
Meanwhile, shares of the company traded ex-date for stock split or sub-division. The stock opened upside at Rs 132.95 apiece on the BSE and surged around 10 per cent on to touch an intraday high of Rs 142.30 per share. The counter had closed at Rs 129.39 per share in the previous session.
Earlier, the board approved the sub-division of shares in the ratio of 5:1, meaning each stock having a face value will be split into five equity shares of Re 1 each.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
Power of Compounding: How many years will it take to reach Rs 3 crore corpus if your monthly SIP is Rs 4,000, Rs 5,000, or Rs 6,000
IRCTC Dividend 2024: Railway PSU announces 200% interim dividend - Check record date and other details
Power of Compounding: Salary Rs 25,000 per month; is it possible to create over Rs 2.60 crore corpus; understand it through calculations
Reduce Home Loan EMI vs Reduce Tenure: Rs 75 lakh, 25-year loan; which option can save Rs 25 lakh and 64 months and how? Know here
Top 7 Large and Mid Cap Mutual Funds with Best SIP Returns in 5 Years: No. 1 fund has turned Rs 15,000 monthly SIP investment into Rs 20,54,384; know about others
New Year Pick by Anil Singhvi: This smallcap stock can offer up to 75% return in long term - Check targets
PSU Oil Stocks: Here's what brokerage suggests on these 2 largecap, 1 midcap scrips - Buy, Sell or Hold?
03:41 PM IST